
With Abbott’s $1.5 billion settlement of a whistleblower-initiated case this week, Abbott joins an infamous list of pharma companies that have paid more than one billion dollars to the federal government for illegal marketing practices, including promoting prescription drugs for uses not approved by the FDA, paying financial inducements to increase sales and engaging in practices that pose grave danger to patients’ health and lives.








Follow Us!